| Nusinersen versus sham control in infantile-onset spinal muscular atrophy DVDC Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J ... N Engl J Med. 377, 2017 | 1984* | 2017 |
| Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study D De Vivo, E Bertini, K Swoboda, WL Hwu, T Crawford, R Finkel, ... Neuromuscular Disorders 29 (11), 2019 | 515 | 2019 |
| Ataluren treatment of patients with nonsense mutation dystrophinopathy K Bushby, R Finkel, B Wong, R Barohn, C Campbell, GP Comi, ... Muscle & nerve 50 (4), 477-487, 2014 | 502 | 2014 |
| Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial CM McDonald, C Campbell, RE Torricelli, RS Finkel, KM Flanigan, ... The Lancet 390 (10101), 1489-1498, 2017 | 446 | 2017 |
| Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study CM McDonald, EK Henricson, RT Abresch, T Duong, NC Joyce, F Hu, ... The Lancet 391 (10119), 451-461, 2018 | 413 | 2018 |
| A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders Z Stark, TY Tan, B Chong, GR Brett, P Yap, M Walsh, A Yeung, H Peters, ... Genetics in medicine 18 (11), 1090-1096, 2016 | 399 | 2016 |
| Nemaline myopathy: a clinical study of 143 cases MM Ryan, C Schnell, CD Strickland, LK Shield, G Morgan, ST Iannaccone, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 324 | 2001 |
| De novo LMNA mutations cause a new form of congenital muscular dystrophy S Quijano‐Roy, B Mbieleu, CG Bönnemann, PY Jeannet, J Colomer, ... Annals of Neurology: Official Journal of the American Neurological …, 2008 | 306 | 2008 |
| Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration J Wan, M Yourshaw, H Mamsa, S Rudnik-Schöneborn, MP Menezes, ... Nature genetics 44 (6), 704-708, 2012 | 251 | 2012 |
| Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis MA Willemsen, MM Verbeek, EJ Kamsteeg, JF de Rijk-van Andel, A Aeby, ... Brain 133 (6), 1810-1822, 2010 | 235 | 2010 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 234 | 2021 |
| Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study L Bello, H Gordish-Dressman, LP Morgenroth, EK Henricson, T Duong, ... Neurology 85 (12), 1048-1055, 2015 | 202 | 2015 |
| Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy DM Escolar, LP Hache, PR Clemens, A Cnaan, CM McDonald, ... Neurology 77 (5), 444-452, 2011 | 197 | 2011 |
| Nemaline myopathy caused by mutations in the muscle α-skeletal-actin gene B Ilkovski, ST Cooper, K Nowak, MM Ryan, N Yang, C Schnell, HJ Durling, ... The American Journal of Human Genetics 68 (6), 1333-1343, 2001 | 179 | 2001 |
| Neuromuscular disorders of infancy, childhood, and adolescence: a clinician's approach BT Darras, HR Jones Jr, MM Ryan, C Darryl Elsevier, 2014 | 174 | 2014 |
| Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial J Burns, RA Ouvrier, EM Yiu, PD Joseph, AJ Kornberg, MC Fahey, ... The Lancet Neurology 8 (6), 537-544, 2009 | 172 | 2009 |
| Neurofilament as a potential biomarker for spinal muscular atrophy BT Darras, TO Crawford, RS Finkel, E Mercuri, DC De Vivo, M Oskoui, ... Annals of clinical and translational neurology 6 (5), 932-944, 2019 | 163 | 2019 |
| Heterogeneity of nemaline myopathy cases with skeletal muscle α‐actin gene mutations PB Agrawal, CD Strickland, C Midgett, A Morales, DE Newburger, ... Annals of neurology 56 (1), 86-96, 2004 | 152 | 2004 |
| Induced dystrophin exon skipping in human muscle explants G Mcclorey, AM Fall, HM Moulton, PL Iversen, JE Rasko, M Ryan, ... Neuromuscular Disorders 16 (9-10), 583-590, 2006 | 149 | 2006 |
| Outcome of noninvasive ventilation in children with neuromuscular disease HK Young, A Lowe, DA Fitzgerald, C Seton, KA Waters, E Kenny, ... Neurology 68 (3), 198-201, 2007 | 146 | 2007 |
